Bezafibrate, a peroxisome proliferator-activated receptor α agonist, decreases circulating CD14(+)CD16(+) monocytes in patients with type 2 diabetes (Q87609752)
Jump to navigation
Jump to search
scientific article published on 30 July 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Bezafibrate, a peroxisome proliferator-activated receptor α agonist, decreases circulating CD14(+)CD16(+) monocytes in patients with type 2 diabetes |
scientific article published on 30 July 2014 |
Statements
Bezafibrate, a peroxisome proliferator-activated receptor α agonist, decreases circulating CD14(+)CD16(+) monocytes in patients with type 2 diabetes (English)
Tomoko Terasawa
Yoshimasa Aso
Kyoko Omori
Maiko Fukushima
Atsushi Momobayashi
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference